Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

Humoral immune responses to periodontal pathogens in the elderly

  • Shet, Uttom (Department of Oral & Maxillofacial Surgery, Chonnam National University School of Dentistry) ;
  • Oh, Hee-Kyun (Department of Oral & Maxillofacial Surgery, Chonnam National University School of Dentistry) ;
  • Chung, Hyun-Ju (Department of Periodontology, Chonnam National University School of Dentistry) ;
  • Kim, Young-Joon (Department of Periodontology, Chonnam National University School of Dentistry) ;
  • Kim, Ok-Su (Department of Periodontology, Chonnam National University School of Dentistry) ;
  • Lim, Hoi-Jeong (Department of Orthodontics, Chonnam National University School of Dentistry) ;
  • Shin, Min-Ho (Department of Preventive Medicine, Chonnam National University Medical School) ;
  • Lee, Seok-Woo (Department of Periodontology, Chonnam National University School of Dentistry)
  • Received : 2015.09.10
  • Accepted : 2015.10.15
  • Published : 2015.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Elderly people are thought to be more susceptible to periodontal disease due to reduced immune function associated with aging. However, little information is available on the nature of immune responses against putative periodontal pathogens in geriatric patients. The purpose of this study was to evaluate the serum IgG antibody responses to six periodontal pathogens in geriatric subjects. Methods: The study population consisted of 85 geriatric patients and was divided into three groups: 29 mild (MCP), 27 moderate (MoCP), and 29 severe (SCP) chronic periodontitis patients. Serum levels of IgG antibody to Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, and Prevotella intermedia were measured by enzyme-linked immunosorbent assay (ELISA) and compared among the groups. Results: All three groups showed levels of serum IgG in response to P. gingivalis, A. actinomycetemcomitans, and P. intermedia that were three to four times higher than levels of IgG to T. forsythia, T. denticola, and F. nucleatum. There were no significant differences among all three groups in IgG response to P. gingivalis (P=0.065), T. forsythia (P=0.057), T. denticola (P=0.1), and P. intermedia (P=0.167), although the IgG levels tended to be higher in patients with SCP than in those with MCP or MoCP (with the exception of those for P. intermedia). In contrast, there were significant differences among the groups in IgG levels in response to F. nucleatum (P=0.001) and A. actinomycetemcomitans (P=0.003). IgG levels to A. actinomycetemcomitans were higher in patients with MCP than in those with MoCP or SCP. Conclusions: When IgG levels were compared among three periodontal disease groups, only IgG levels to F. nucleatum significantly increased with the severity of disease. On the contrary, IgG levels to A. actinomycetemcomitans decreased significantly in patients with SCP compared to those with MCP. There were no significant differences in the IgG levels for P. gingivalis, T. forsythia, T. denticola, and P. intermedia among geriatric patients with chronic periodontitis.

Keywords

References

  1. Lee R. The outlook for population growth. Science 2011;333: 569-73. https://doi.org/10.1126/science.1208859
  2. Dave S, Van Dyke T. The link between periodontal disease and cardiovascular disease is probably inflammation. Oral Dis 2008;14: 95-101. https://doi.org/10.1111/j.1601-0825.2007.01438.x
  3. Katz J, Wallet S, Cha S. Periodontal disease and the oral-systemic connection: "is it all the RAGE?". Quintessence Int 2010;41:229-37.
  4. Papapanou PN. Systemic effects of periodontitis: lessons learned from research on atherosclerotic vascular disease and adverse pregnancy outcomes. Int Dent J. Forthcoming 2015.
  5. Cullinan MP, Seymour GJ. Periodontal disease and systemic illness: will the evidence ever be enough? Periodontol 2000 2013;62: 271-86. https://doi.org/10.1111/prd.12007
  6. Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol 2010;104:183-90. https://doi.org/10.1016/j.anai.2009.11.009
  7. Boraschi D, Del Giudice G, Dutel C, Ivanoff B, Rappuoli R, Grubeck-Loebenstein B. Ageing and immunity: addressing immune senescence to ensure healthy ageing. Vaccine 2010;28:3627-31. https://doi.org/10.1016/j.vaccine.2010.03.035
  8. Ebersole JL, Cappelli D, Holt SC. Periodontal diseases: to protect or not to protect is the question? Acta Odontol Scand 2001;59: 161-6. https://doi.org/10.1080/000163501750266756
  9. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994;5:112-41. https://doi.org/10.1111/j.1600-0757.1994.tb00021.x
  10. Darby IB, Mooney J, Kinane DF. Changes in subgingival microflora and humoral immune response following periodontal therapy. J Clin Periodontol 2001;28:796-805. https://doi.org/10.1034/j.1600-051X.2001.280812.x
  11. Ishikawa I, Nakashima K, Koseki T, Nagasawa T, Watanabe H, Arakawa S, et al. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 1997;14:79-111. https://doi.org/10.1111/j.1600-0757.1997.tb00193.x
  12. Teng YT. The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med 2003;14:237-52. https://doi.org/10.1177/154411130301400402
  13. Teng YT. Protective and destructive immunity in the periodontium: Part 1--innate and humoral immunity and the periodontium. J Dent Res 2006;85:198-208. https://doi.org/10.1177/154405910608500301
  14. Craig RG, Boylan R, Yip J, Mijares D, Imam M, Socransky SS, et al. Serum IgG antibody response to periodontal pathogens in minority populations: relationship to periodontal disease status and progression. J Periodontal Res 2002;37:132-46. https://doi.org/10.1034/j.1600-0765.2002.00031.x
  15. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6. https://doi.org/10.1902/annals.1999.4.1.1
  16. Shet UK, Oh HK, Kim HJ, Chung HJ, Kim YJ, Kim OS, et al. Quantitative analysis of periodontal pathogens present in the saliva of geriatric subjects. J Periodontal Implant Sci 2013;43:183-90. https://doi.org/10.5051/jpis.2013.43.4.183
  17. McArthur WP, Bloom C, Taylor M, Smith J, Wheeler T, Magnusson NI. Antibody responses to suspected periodontal pathogens in elderly subjects with periodontal disease. J Clin Periodontol 1995; 22:842-9. https://doi.org/10.1111/j.1600-051X.1995.tb01782.x
  18. De Nardin AM, Sojar HT, Grossi SG, Christersson LA, Genco RJ. Humoral immunity of older adults with periodontal disease to Porphyromonas gingivalis. Infect Immun 1991;59:4363-70.
  19. Califano JV, Gunsolley JC, Schenkein HA, Tew JG. A comparison of IgG antibody reactive with Bacteroides forsythus and Porphyromonas gingivalis in adult and early-onset periodontitis. J Periodontol 1997;68:734-8. https://doi.org/10.1902/jop.1997.68.8.734
  20. Baker PJ, Carter S, Dixon M, Evans RT, Roopenian DC. Serum antibody response to oral infection precedes but does not prevent Porphyromonas gingivalis-induced alveolar bone loss in mice. Oral Microbiol Immunol 1999;14:194-6. https://doi.org/10.1034/j.1399-302X.1999.140309.x
  21. Albandar JM, DeNardin AM, Adesanya MR, Diehl SR, Winn DM. Associations between serum antibody levels to periodontal pathogens and early-onset periodontitis. J Periodontol 2001;72:1463-9. https://doi.org/10.1902/jop.2001.72.11.1463
  22. Nabers CL, Stalker WH, Esparza D, Naylor B, Canales S. Tooth loss in 1535 treated periodontal patients. J Periodontol 1988;59:297-300. https://doi.org/10.1902/jop.1988.59.5.297
  23. Papapanou PN, Wennstrom JL, Grondahl K. Periodontal status in relation to age and tooth type. A cross-sectional radiographic study. J Clin Periodontol 1988;15:469-78. https://doi.org/10.1111/j.1600-051X.1988.tb01602.x
  24. Dye BA, Herrera-Abreu M, Lerche-Sehm J, Vlachojannis C, Pikdoken L, Pretzl B, et al. Serum antibodies to periodontal bacteria as diagnostic markers of periodontitis. J Periodontol 2009;80:634-47. https://doi.org/10.1902/jop.2009.080474
  25. Iwasaki M, Minagawa K, Sato M, Kaneko N, Imai S, Yoshihara A, et al. Serum antibody to Porphyromonas gingivalis in metabolic syndrome among an older Japanese population. Gerodontology. Forthcoming 2014.
  26. Beck JD, Eke P, Heiss G, Madianos P, Couper D, Lin D, et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation 2005;112:19-24. https://doi.org/10.1161/CIRCULATIONAHA.104.511998
  27. Iwasaki M, Taylor GW, Manz MC, Kaneko N, Imai S, Yoshihara A, et al. Serum antibody to Porphyromonas gingivalis in chronic kidney disease. J Dent Res 2012;91:828-33. https://doi.org/10.1177/0022034512455063
  28. Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjonneland A, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 2013;62:1764-70. https://doi.org/10.1136/gutjnl-2012-303006

Cited by

  1. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer vol.6, pp.None, 2015, https://doi.org/10.1038/srep33440
  2. Avidity of serum immunoglobulin G antibodies to Porphyromonas gingivalis in the elderly with chronic periodontitis vol.44, pp.1, 2019, https://doi.org/10.11620/ijob.2019.44.1.14
  3. Variations in IgG antibody subclass responses to oral bacteria: Effects of periodontal disease and modifying factors vol.56, pp.5, 2015, https://doi.org/10.1111/jre.12882